#USA #San Francisco #Series B Funding #General Medicine #Healthcare Store

General Medicine Secures $120 Million to Expand Healthcare Store

In a significant stride towards revolutionizing healthcare access, General Medicine announced today that it has raised $120 million in Series B funding. This investment is led by the notable venture capital firm Andreessen Horowitz (also known as a16z), alongside contributions from other prominent investors such as Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. With this latest round, General Medicine's total funding has now reached an impressive $152 million, marking a pivotal moment in its journey to transform healthcare delivery across the nation.

General Medicine operates as a comprehensive healthcare store where customers have the ability to search, compare, and purchase a wide array of healthcare services and products. The platform provides transparency in pricing by allowing users to view costs with and without insurance. Currently, General Medicine boasts a catalog that includes over 2,900 offerings across medications, lab services, telehealth options, specialist electronic consultations, and selected in-person visits and procedures. This approach is designed to streamline the healthcare experience for users, addressing the common frustrations associated with traditional healthcare models.

Founded in 2023 and launched nationwide in May 2025, General Medicine has quickly garnered a substantial user base, with hundreds of thousands of customers signing up. Impressively, the company has achieved an average Net Promoter Score (NPS) of 80, indicating high customer satisfaction. A significant 83% of users reported that the platform has assisted them in addressing healthcare needs they had previously postponed, and notably, a third of these individuals delayed care for over six months.

The platform's innovation lies in its ability to organize healthcare services around the needs of customers rather than traditional medical specialties or institutional frameworks. This customer-centric model is underscored by insights from TJ Parker, CEO of General Medicine, who stated, "Everyone's building a healthcare AI agent that can tell you what you might need. What's missing is the infrastructure that lets you actually get it." This sentiment reflects a growing acknowledgment that while healthcare advice is increasingly accessible, the challenge remains in the practical execution of these recommendations.

One of the key strategies for General Medicine involves leveraging the new funding to expand its service categories further. At its core is a product catalog that harmonizes various descriptions of services as seen through the lenses of customers, clinicians, insurers, laboratories, and health systems, thus facilitating clearer comparisons and pricing. This innovative structure allows for a seamless experience, where customers can either directly shop for care, consult with a licensed clinician—often on the same day—or explore options through General Medicine's AI chat feature based on their symptoms or health goals. Understanding the patient's health history is integral to each of these pathways, ensuring that clinical reviews are handled appropriately and with foresight.

Notably, the independence of clinical decision-making is maintained within the platform; transactional relationships do not dictate which products or treatments are available to customers. Ashwin Muralidharan, Chief Product Officer at General Medicine, emphasized that healthcare should be organized by need rather than by specialty, stating: "Consumers don't shop by specialty. They shop by need. We built the store to start with the need and organize everything underneath it to move someone from 'I have a problem' to 'I've done something about it' as quickly as possible."

General Medicine has set out to address the convoluted process often associated with accessing healthcare, with Elliot Cohen, the company's President, highlighting the challenges many consumers face when attempting to navigate the complicated healthcare landscape. He remarked, "When a customer can actually see their options and the price, the rest of the system has to compete, instead of the customer trying to navigate a system not built for them."

As General Medicine looks to the future, the company remains committed to not only enhancing patient experiences but also innovating solutions that extend to all types of care. The funding will aid in developing tools and processes that can facilitate even broader access and improved patient outcomes. Agarwala, a partner at a16z, praised the venture, noting the platform's capability to create a streamlined user experience, drawing attention to features like one-click medical record collection and timely specialist consultations.

In summary, General Medicine's recent funding marks a vital milestone in its mission to provide accessible, straightforward, and effective healthcare solutions to consumers across the nation. Customer-centric innovation paired with substantial financial backing positions General Medicine at the forefront of the evolving healthcare landscape, promising to redefine how individuals interact with their health needs and the overarching healthcare system.